Latest filing published 03 May 2019 for Intercept Pharmaceuticals, INC., €57k.
Filing timeline
BuySaleFirst 200 filings with a declared amount
Insider track record
David Shapiro: trading record in brief
David Shapiro appears in our data through filings on Intercept Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 April 2013 to 1 May 2019, the count stands at 254 filings.
No open-market purchase appears, only 171 sales worth €30.5M. The rest of the record consists of 14 share grants and 69 option exercises. Since January 2019: no purchases and 8 sales on the market.
On 3 May 2019 came the latest disclosure, an option exercise for €57k in Intercept Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to David Shapiro
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-19-023712:0
- 2,000 shares@ US$86.285.1% of flowCommon StockSEC:0001144204-19-023712:1
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-19-019949:0
- 2,000 shares@ US$95.005.6% of flowCommon StockSEC:0001144204-19-019949:1
- 482 shares@ US$111.501.6% of flowCommon StockSEC:0001144204-19-018081:0
- 562 shares@ US$115.011.9% of flowCommon StockSEC:0001144204-19-018081:1
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-19-011719:0
- 2,000 shares@ US$103.166.0% of flowCommon StockSEC:0001144204-19-011719:1
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-19-009186:0
- 2,000 shares@ US$111.516.6% of flowCommon StockSEC:0001144204-19-009186:1
- 3,300 shares0Common StockSEC:0001144204-19-002142:0
- 474 shares@ US$97.481.3% of flowCommon StockSEC:0001144204-19-000723:0
- 736 shares@ US$100.792.1% of flowCommon StockSEC:0001144204-19-000502:0
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-19-000502:1
- 2,000 shares@ US$98.285.7% of flowCommon StockSEC:0001144204-19-000502:2
- 699 shares@ US$97.452.0% of flowCommon StockSEC:0001144204-19-000502:3
- 2,000 shares@ US$31.901.9% of flowCommon StockSEC:0001144204-18-065469:0
- 2,000 shares@ US$106.626.3% of flowCommon StockSEC:0001144204-18-065469:1
- 2,000 shares@ US$21.501.3% of flowCommon StockSEC:0001144204-18-057130:0
- 2,000 shares@ US$96.325.6% of flowCommon StockSEC:0001144204-18-057130:1
- 3,425 shares@ US$21.502.1% of flowCommon StockSEC:0001144204-18-054076:0
- 3,425 shares@ US$102.9510.1% of flowCommon StockSEC:0001144204-18-054076:1
- 759 shares@ US$110.652.4% of flowCommon StockSEC:0001144204-18-052813:0
- 1,020 shares@ US$58.421.6% of flowCommon StockSEC:0001144204-18-052409:0
- 423 shares@ US$61.520.7% of flowCommon StockSEC:0001144204-18-052409:1
25 of 254 declarations
